Active · per the CBE, 30 September 2026
Dr. Kristel VAN CRAENENBROECK-huisartsengeneeskunde logo

Dr. Kristel VAN CRAENENBROECK-huisartsengeneeskunde

BE0895231113

Rechtspersoon Private limited company

Dr. Kristel VAN CRAENENBROECK-huisartsengeneeskunde is a general practice in Zemst. Private Limited, started on 25 January 2008.

Windmolenstraat 4, 1980 Zemst drvancraenenbroeck.be

Behind the company: Kristel Van Craenenbroeck.

Active for

18 year, 8 months

Financials

Financial year 2025

Dr. Kristel VAN CRAENENBROECK-huisartsengeneeskunde from Zemst, company number BE0895231113, closed financial year 2025 with a result of € 165,592 after tax. For that financial year Dr. Kristel VAN CRAENENBROECK-huisartsengeneeskunde recorded a gross margin of € 298,177 and equity of € 802,609. Compared with financial year 2024, the result moved from € 162,427 to € 165,592. Profitable, and profit is growing. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 29, 2026.

What it is worth Healthy

€ 802,609

▼ 12% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 165,592

▲ 2% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 348,658

▲ € 272,153 vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 271,811 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Vehicles and equipment

€ 16,452

▼ 47% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 8,462

▲ € 7,061 vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 17,763

▲ € 16,518 vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
2022202320242025Change 2024 → 2025
Gross margin € 298,630 € 289,232 € 297,432 € 298,177
Profit after taxes € 177,578 € 156,138 € 162,427 € 165,592 ▲ 2%
Equity € 695,713 € 810,199 € 908,828 € 802,609 ▼ 12%
Total debts € 156,007 € 180,404 € 145,809 € 54,323 ▼ 63%
Cash € 191,006 € 79,591 € 76,505 € 348,658 ▲ € 272,153
Land & buildings € 107,000 € 94,822 € 82,645 € 70,468 ▼ 15%
Retained profit € 683,313 € 797,799 € 896,428 € 790,209 ▼ 12%
Dividend € 63,574 € 41,652 € 63,798 € 271,811 ▲ € 208,013
Bank debt € 42,487 € 22,948 € 4,705 € 0 ▼ 100%
Balance sheet total € 851,720 € 990,603 € 1,054,637 € 856,931 ▼ 19%

Key figures of Dr. Kristel VAN CRAENENBROECK-huisartsengeneeskunde, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Dr. Kristel VAN CRAENENBROECK-huisartsengeneeskunde?

What happened at Dr. Kristel VAN CRAENENBROECK-huisartsengeneeskunde in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2025: profit of € 165,592 (▲ 2% vs 2024). Source: NBB ↗
  • Kristel Van Craenenbroeck became a director. NBB
  • Start of the company according to the CBE. KBO

In short

From € 177,578 profit in 2022 to € 165,592 profit in 2025.

Paid € 287,897 in corporate taxes since 2022.

Best year ever: 2022, with € 177,578 profit.

Paid out € 440,835 in dividends to the owners in total.

Management

Kristel Van Craenenbroeck
Dr. Kristel VAN CRAENENBROECK-huisartsengeneeskunde

Behind Dr. Kristel VAN CRAENENBROECK-huisartsengeneeskunde is Kristel Van Craenenbroeck.

See the full network in the app

Directors

According to the 2025 annual accounts

Kristel Van Craenenbroeck

Director

since 2023

Establishments

Establishment units

Physical locations of this company

Registered office

Windmolenstraat 4

1980 Zemst

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Website

Technologies

Google AnalyticsGoogle MapsjQuery

Hosting & Email

Email provider

Self-hosted

Hosting

LEVEL27-AS * Please direct all complaints to [email protected] *, BE

Domain

Domain

drvancraenenbroeck.be

Registered

2011-08-31

Website info

HTTPS Ja

Features

Security

✓ HTTPS
✗ SPF
✗ DMARC

Details

Company number
0895.231.113
VAT number
BE 0895.231.113
Registered office
Windmolenstraat 4, 1980 Zemst
Names & denominations
Dr. Kristel VAN CRAENENBROECK-huisartsengeneeskunde
Enterprise type
Rechtspersoon
Legal form
Private limited company
Legal situation
Normale toestand
Start date
25 January 2008
Peppol
Active · Active since 14 Jan 2026
Activities · NACE

Activiteiten van huisartspraktijken

Frequently asked questions

What does Dr. Kristel VAN CRAENENBROECK-huisartsengeneeskunde do?
Dr. Kristel VAN CRAENENBROECK-huisartsengeneeskunde is a general practice in Zemst. Private Limited, started on 25 January 2008.
What is the address of Dr. Kristel VAN CRAENENBROECK-huisartsengeneeskunde?
The registered office of Dr. Kristel VAN CRAENENBROECK-huisartsengeneeskunde is located at Windmolenstraat 4, 1980 Zemst.
Is Dr. Kristel VAN CRAENENBROECK-huisartsengeneeskunde still active?
Yes. According to the CBE (30 September 2026) Dr. Kristel VAN CRAENENBROECK-huisartsengeneeskunde is active, legal situation “Normale toestand”, started on 25 January 2008.
Is Dr. Kristel VAN CRAENENBROECK-huisartsengeneeskunde registered on Peppol?
Yes, Dr. Kristel VAN CRAENENBROECK-huisartsengeneeskunde is registered on the Peppol network with ID 0208:0895231113.
What is the enterprise number of Dr. Kristel VAN CRAENENBROECK-huisartsengeneeskunde?
The enterprise number of Dr. Kristel VAN CRAENENBROECK-huisartsengeneeskunde is BE0895231113.
When was Dr. Kristel VAN CRAENENBROECK-huisartsengeneeskunde founded?
Dr. Kristel VAN CRAENENBROECK-huisartsengeneeskunde was founded on 25 January 2008.